ETHZilla plans to raise $10 billion through a rights offering to support continued ETH purchases

2025/08/23 21:16

PANews reported on August 23rd that Strategic ETH Reserve announced in a post on the X platform that ETHZilla (formerly 180 Life Sciences Corp.), a Nasdaq-listed Ethereum treasury company, has disclosed that it has amended its previously executed securities sales agreement regarding the issuance of common stock in the prospectus supplement and accompanying prospectus. Under the terms of the amended sales agreement, the company will be able to raise up to $10,000,000.000 through the issuance and sale of shares of common stock to support its continued purchase of ETH.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights